Gaona L. Shi
State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Immunomodulatory supramolecular hydrogel for rheumatoid arthritis management via adenosine A2A receptor-mediated macrophage remodeling.
Journal: Bioactive materials
Published: August 20, 2025
Hepatocyte Mettl3 Deficiency Drives Primary Sclerosing Cholangitis and Liver Fibrosis via Cholangiocyte-Macrophage Crosstalk.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 09, 2025
Fine-tuning of stable organic free-radical photosensitizers for photodynamic immunotherapy.
Journal: Chemical science
Published: December 19, 2023
Unravelling Immune-Inflammatory Responses and Lysosomal Adaptation: Insights from Two-Photon Excited Delayed Fluorescence Imaging.
Journal: Advanced healthcare materials
Published: November 29, 2023
A synthetic derivative of bioactive constituents from Isatis indigotica ameliorates hypersensitivity and arthritis by inhibiting JAK2-STAT3 pathway in mice.
Journal: International immunopharmacology
Published: June 02, 2023
JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes.
Journal: Acta pharmaceutica Sinica. B
Published: March 15, 2023
Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A/2B receptors in tolerogenic dendritic cells.
Journal: Acta pharmaceutica Sinica. B
Published: February 02, 2023
Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast-Myofibroblast Transformation against Pulmonary Fibrosis.
Journal: ACS chemical biology
Published: September 08, 2022
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine-related JAK-STAT signal.
Journal: Science advances
Published: August 19, 2022
Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis.
Journal: Pharmacology & therapeutics
Published: December 31, 2020
Exploring a novel triptolide derivative possess anti-colitis effect via regulating T cell differentiation.
Journal: International immunopharmacology
Published: June 26, 2020
A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 04, 2020
Last Updated: 09/26/2026